Tech Company Financing Transactions

Amplyx Pharmaceuticals Funding Round

On 5/20/2020, Amplyx Pharmaceuticals raised $53 million in Series C investment from Sofinnova Ventures, 3x5 Partners and Adage Capital Management.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The company will use the proceeds of the financing to advance the clinical development of its product candidates, fosmanogepix and MAU868.

Company Information

Company Status
Acquired or Merged
Mailing Address
12730 High Bluff Dr. 160
San Diego, CA 92130
Email Address
Amplyx Pharmaceuticals is developing novel, broad-spectrum antifungal agents for the treatment of life-threatening fungal infections.
Amplyx Pharmaceuticals LinkedIn Company Profile
Social Media
Amplyx Pharmaceuticals Company Twitter Account
Company News
Amplyx Pharmaceuticals News
Amplyx Pharmaceuticals on Facebook
Amplyx Pharmaceuticals on YouTube

Management Team

Email & Social
Michael Grey
  Michael Grey LinkedIn Profile  Michael Grey Twitter Account  Michael Grey News  Michael Grey on Facebook
Chief Executive Officer
Ciara Kennedy
  Ciara Kennedy LinkedIn Profile  Ciara Kennedy Twitter Account  Ciara Kennedy News  Ciara Kennedy on Facebook
Chief Financial Officer
Alan Fuhrman
  Alan Fuhrman LinkedIn Profile  Alan Fuhrman Twitter Account  Alan Fuhrman News  Alan Fuhrman on Facebook
Chief Medical Officer
Michael Hodges
  Michael Hodges LinkedIn Profile  Michael Hodges Twitter Account  Michael Hodges News  Michael Hodges on Facebook
VP - Bus. Development
Kevin Holme
  Kevin Holme LinkedIn Profile  Kevin Holme Twitter Account  Kevin Holme News  Kevin Holme on Facebook
VP - Operations
Paul Bien
  Paul Bien LinkedIn Profile  Paul Bien Twitter Account  Paul Bien News  Paul Bien on Facebook
VP - Operations
Pamela Wedel
  Pamela Wedel LinkedIn Profile  Pamela Wedel Twitter Account  Pamela Wedel News  Pamela Wedel on Facebook
VP - Regulatory Affairs
Elizabeth Gordon
  Elizabeth Gordon LinkedIn Profile  Elizabeth Gordon Twitter Account  Elizabeth Gordon News  Elizabeth Gordon on Facebook



Browse more venture capital transactions:

Prev: 5/20/2020: Nivagen Pharmaceuticals venture capital transaction
Next: 5/20/2020: Leafly venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary